Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
EP.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.17.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CM.7.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.10.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FD.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KG.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HA.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.351 (Beta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.36EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HZ.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.30EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.19.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.100EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.16.19EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.43.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EU.1.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.18EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.507EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.178EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.273EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.211EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.474EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.160.14EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.297EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AH.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.280EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.597EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.45EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.72EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.43EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.85EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.66 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.72 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.133 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.5.1 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.43.7 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.33.1 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.493EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.351.2 (Beta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.640.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.352EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.251EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HC.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XCJEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FT.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.48EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used